Wednesday, 28 May 2008

Announcement: BBP153 Sold

NNRTI BBP153 has been sold under a secrecy agreement. As a consequence bbPharma will no longer develop BBP153 in HIV or related conditions.

Edwin ten Winkel, CEO

No comments:

Post a Comment